The Radiopharmaceutical Therapy and Dosimetry Lab at Johns Hopkins Medicine, headed by George Sgouros, Ph.D., has been awarded a $15 million grant, to be dispersed over the next five years, from the ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new, clinically validated genetic ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Doctors sometimes use radiation therapy to treat early stage non-Hodgkin’s lymphoma (NHL). To treat advanced stages, they may recommend radiation therapy alongside other treatments, such as ...

Mixed-Methods Study of End-of-Life Experiences of Patients With Hematologic Malignancies in Social Hospice Residential Home Care Settings With the expansion of proton radiation therapy centers across ...

Please provide your email address to receive an email when new articles are posted on . Patients with Medicaid coverage had significantly higher odds of experiencing interruptions in radiation therapy ...

Radiation-related hearing loss in children with ependymoma to cognitive decline, urging cochlear protection and hearing support.

A new type of radiation sensor out of Sandia National Laboratories could yield benefits in applications ranging from cancer ...